Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

MODIFICATION OF NERVE RESPONSE BY VERATRINE, PROTOVERATRINE AND ACONITINE

HELEN TREDWAY GRAHAM and HERBERT S. GASSER
Journal of Pharmacology and Experimental Therapeutics September 1931, 43 (1) 163-185;
HELEN TREDWAY GRAHAM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HERBERT S. GASSER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

1. The effect of veratrine on nerve may be divided into two stages. The first stage shows the typical veratrine effect: a greatly augmented and prolonged after-potential. It is associated with a prolonged supernormal phase and a lowered threshold of excitation of the resting nerve. The second stage is produced by greater intensity or duration of action. The magnitude of the after-potential begins to decrease and other indications of nerve deterioration become manifest, such as decreased conduction-rate, increased relatively refractory period, raised threshold of excitation and fall of the spike height. The absolutely refractory period and the time constants of the axon spike do not change throughout the veratrinization.

2. After a period of rapid stimulation, the after-potential of veratrinized nerve is increased, and its rising-phase prolonged, SO that its maximum falls 30 to 80 sigmas after the shock. Rest brings about a return of the nerve towards its previous state.

3. During a period of asphyxia, the veratrine after-potential is decreased; with the readmission of oxygen, the after-potential is increased above its initial value, and assumes the form seen after rapid stimulation.

4. Cooling decreases the veratrine after-potential; this change is less rapidly reversible on warming than is the change in spikeform.

5. Anesthetics (urethane, ether vapor) may either increase or decrease the amplitude of the veratrine after-potential. They tend to prolong the rising-phase of the after-potential.

6. Protoveratrine and aconitine produce a prolonged after-potential much lower than that caused by veratrine.

Footnotes

    • Received May 9, 1931.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 43, Issue 1
1 Sep 1931
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
MODIFICATION OF NERVE RESPONSE BY VERATRINE, PROTOVERATRINE AND ACONITINE
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

MODIFICATION OF NERVE RESPONSE BY VERATRINE, PROTOVERATRINE AND ACONITINE

HELEN TREDWAY GRAHAM and HERBERT S. GASSER
Journal of Pharmacology and Experimental Therapeutics September 1, 1931, 43 (1) 163-185;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

MODIFICATION OF NERVE RESPONSE BY VERATRINE, PROTOVERATRINE AND ACONITINE

HELEN TREDWAY GRAHAM and HERBERT S. GASSER
Journal of Pharmacology and Experimental Therapeutics September 1, 1931, 43 (1) 163-185;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Meeting Report for the ASPET–Ray Fuller Symposium: Cellular Mechanisms and Novel Strategies for Pain Control
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics